Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

518 public trials 102 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

NCT03703297

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Santa Rosa, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Fort Myers, Florida, United States
View all 183 locations
View Trial Details
Active, Not Recruiting

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

NCT05812027

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +43 more
Locations
  • HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)

NCT04035486

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
Locations
  • Research Site Bellflower, California, United States
  • Research Site Fullerton, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Santa Monica, California, United States
View all 153 locations
View Trial Details
Active, Not Recruiting

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

NCT03937219

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Exelixis Clinical Site #116 La Jolla, California, United States
  • Exelixis Clinical Site #166 Orange, California, United States
  • Exelixis Clinical Site #29 Boca Raton, Florida, United States
  • Exelixis Clinical Site #44 Miami, Florida, United States
View all 159 locations
View Trial Details
Active, Not Recruiting

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

NCT05226507

Conditions
ARID1A Gene Mutation, Adenocarcinoma, Adnexal Diseases, +24 more
Locations
  • Honor Health Phoenix, Arizona, United States
  • UC San Diego Health - Moores Cancer Center La Jolla, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale Gynecologic Oncology New Haven, Connecticut, United States
View all 22 locations
View Trial Details

Related conditions